Oregon Medication Error Lawyer

How Medication Errors Happen in Oregon

Medication errors are systems failures. The medication-use process has five stages — prescribing, transcribing, dispensing, administering, and monitoring — and an error at any stage can produce harm. Modern health-care systems are built with independent checks at multiple stages: the prescriber should check the patient's drug list and allergies, the electronic prescribing system should flag interactions, the pharmacist should verify the prescription against the diagnosis and the patient profile, the nurse should perform the five-rights check before administration (right patient, right drug, right dose, right route, right time), and the monitoring plan should catch toxic effects before they become irreversible. Errors typically result from multiple checks failing in sequence, often because the system is overloaded or short-staffed.

Prescribing errors include wrong-drug selection (a drug not indicated for the diagnosis, contraindicated by an allergy, or dangerous in combination with another drug the patient is taking), dose errors (especially in pediatric weight-based dosing or renally adjusted dosing), and failure to recognize the need for monitoring (warfarin without scheduled INRs, vancomycin without trough levels, methotrexate without hepatic monitoring).

Dispensing errors include filling the prescription with the wrong drug (look-alike/sound-alike drug names are a recurring hazard), filling with the wrong strength, and missing a significant interaction or duplicate therapy that the pharmacy system should have flagged. Administration errors include wrong-patient administration (most often in hospitalized patients), wrong-route administration (intrathecal vs. intravenous, for example, which can be fatal), and infusion-rate errors. Monitoring errors include failure to act on critical lab values, failure to recognize signs of toxicity, and failure to adjust dosing for changing kidney or liver function.

Two specific patterns produce a disproportionate share of Oregon medication-error claims. Anticoagulant management failures — supra-therapeutic INRs that produce intracranial or gastrointestinal hemorrhage — are common in elderly outpatients whose dosing is not adjusted after changes in diet, weight, or interacting medications. Opioid-related respiratory depression — particularly when combined with benzodiazepines or other sedating drugs — is a recurring pattern in hospitalized patients, post-surgical patients, and chronic-pain patients whose monitoring is inadequate.

Common Injuries & Outcomes

Medication-error injuries span the full range of severity. Anticoagulant overdose causes intracranial hemorrhage, gastrointestinal bleeding, and fatal hemorrhage. Opioid overdose causes respiratory depression, hypoxic brain injury, and death. Insulin overdose causes severe hypoglycemia, seizure, and brain injury. Chemotherapy dosing errors can produce bone-marrow suppression with fatal sepsis. Drug-induced liver injury can require transplant or be fatal. Drug interactions can produce QT prolongation and lethal arrhythmias.

For families, medication-error deaths produce wrongful-death claims under ORS 30.020 with their own three-year limitations period. Permanent hypoxic-injury cases from opioid-related respiratory depression and severe-hypoglycemia cases from insulin overdose produce life-care costs comparable to other catastrophic-injury claims.

What Proof an Oregon Medication-Error Case Requires

Oregon requires expert testimony from the appropriate discipline depending on the defendant. Prescribing-error cases require physician testimony (typically in the same specialty as the prescriber). Pharmacy cases require expert pharmacist testimony. Hospital administration and nursing cases require nursing standard-of-care testimony and, often, expert hospital-pharmacy testimony on the system failures that allowed the error to occur. The medication-administration record (MAR), the pharmacy fill records, the prescribing audit trail in the EHR, and any incident reports the facility prepared are central evidence sources.

Causation in medication-error cases is often more direct than in missed-diagnosis cases — the drug interaction or overdose produced the harm, and the medical literature supports the causal chain. The defense often shifts to comparative-fault arguments (the patient did not disclose another medication, the patient did not follow instructions, the patient took additional doses on their own) which Oregon's modified comparative-negligence rule under ORS 31.600 allows but limits.

Applicable Oregon Statutes

• ORS 12.110 — Two-year discovery-rule SOL; five-year repose in subsection (4).
• ORS 677.095 — Standard of care for Oregon physicians.
• ORS 689.155 — Duties of Oregon pharmacists in dispensing prescription drugs, including the obligation to exercise professional judgment.
• ORS 30.275 — OTCA 180-day notice requirement for medication-error cases involving public hospitals and clinics.
• ORS 30.020 — Wrongful-death cause of action when a medication error results in death.
• ORS 31.730 — Punitive damages for reckless and outrageous indifference; relevant where a facility had documented repeat errors and did not act.

How Todd Evaluates a Medication-Error Case

Medication-error cases turn on the records: the prescription record (including any EHR audit trail showing what alerts were triggered and how they were handled), the pharmacy dispense record, the medication-administration record (MAR) from the facility, any pharmacist counseling notes, lab values that should have prompted dose adjustment, the patient's home medication list at the time of the error, and the records of the resulting injury. Hospital incident reports and root-cause analyses are often discoverable in litigation and frequently reveal that the facility identified the systemic problem but did not fix it.

Huegli Law engages the appropriate experts — physician, pharmacist, nursing, hospital pharmacy — to review the case and form opinions on standard of care and causation. The firm has handled cases against major hospital systems, retail pharmacy chains, and nursing facilities; the discovery work in these cases often involves obtaining facility policies, staffing records, training records, and incident logs that show whether the error was an isolated event or part of a pattern.

What a Medication-Error Case Is Worth

Case value depends on the severity of the injury, the strength of the causation evidence, the available insurance, and the venue. Errors that produced limited and recoverable harm may resolve in the low to mid six figures. Errors that produced permanent injury — anoxic brain injury from opioid overdose, intracranial hemorrhage from anticoagulant overdose, severe hypoglycemic brain injury — typically resolve in the seven figures or higher. Wrongful-death cases depend on the decedent's circumstances and the surviving beneficiaries. Past results do not guarantee future outcomes; case value is fact-specific.

Statute of Limitations: Specific Notes for Medication Errors

Medication-error cases have two SOL features worth flagging. First, in chronic-medication cases where the injury developed over months or years (gradual liver injury, gradual kidney injury, accumulating bone-marrow suppression), the discovery date under ORS 12.110 can be later than the first negligent prescription — but the five-year repose still bars claims arising more than five years before filing absent fraud or concealment. Second, the OTCA 180-day notice requirement under ORS 30.275 applies when the prescriber, pharmacist, or facility is a public entity, and runs from the date of injury. Both deadlines run quickly relative to the time it typically takes for a serious medication injury to be understood; early consultation matters.